Pneumonia
Conditions
Keywords
Prevention of pneumonia, ceftriaxone, continuous aspiration, subglottic secretions, Mechanical ventilation with Endotracheal intubation., Absence of infection
Brief summary
The primary purpose of the trial is to compare the efficacy and safety of two measures which claim to prevent early-onset ventilator-associated pneumonia.
Detailed description
Background: In a previous double-blind, placebo-controlled, randomized trial we found that a 3-day-course of ceftriaxone significantly reduced the incidence of early-onset ventilator-associated pneumonia (EOP). Continuous aspiration of secretions accumulating in the subglottic space above the cuff of the endotracheal tube has also been shown to prevent EOP. Objective: To compare the effect of both preventive measures on the incidence of EOP. Design: Randomized, multicenter. Setting: Three general intensive care units at university hospitals in Spain. Patients: Patients without signs of infection and no concomitant systemic antibiotics were included if expected to require endotracheal intubation exceeding 2 days. Intervention: All patients were intubated with an endotracheal tube equipped with a port for aspiration of subglottic secretions and subsequently randomized to receive a three day course of 2 gram/day iv ceftriaxone without aspiration of subglottic secretions or continuous aspiration of subglottic secretions. Measurements: All ICU-acquired infections, antibiotic therapy, colonization and infection with 3rd-generation cephalosporin-resistant microorganisms, duration of intubation and ICU-stay and-mortality.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Endotracheal intubation with endotracheal tube equipped with port for aspirations of subglottic contents and expected to exceed 48 hors. * Absence of infection. * 18 years or older. * Informed Consent.
Exclusion criteria
* Endotracheal intubation prior to admission to hospital. * Allergic to beta-lactam antibiotics. * Formal indication for systemic antibiotic therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative incidence of early-onset ventilator-associated pneumonia | — |
Secondary
| Measure | Time frame |
|---|---|
| All ICU-acquired infections. | — |
| Duration of antibiotic therapy. | — |
| Third-generation cephalosporin resistance. | — |
| Duration of intubation and ICU-stay. | — |
| ICU-Mortality. | — |
Countries
Spain